Alexion Pharmaceuticals Inc ALXN:NASDAQ

Last Price$115.33NASDAQ Previous Close - Last Trade as of 4:00PM ET 8/23/19
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$115.50 (1)
Ask (Size)$118.50 (21)
Day Low / HighN/A - N/A
Volume5.2 M
 

View Biotechnology IndustryPeer Comparison as of 08/23/2019

 

Alexion Pharmaceuticals Inc ( NASDAQ )

Price: $115.33
Change: -8.16 (6.61%)
Volume: 5.2 M
4:00PM ET 8/23/2019
 
 

Agilent Technologies Inc ( NYSE )

Price: $69.55
Change: -2.19 (3.05%)
Volume: 3.0 M
6:30PM ET 8/23/2019
 
 

Regeneron Pharmaceuticals Inc ( NASDAQ )

Price: $286.85
Change: -8.17 (2.77%)
Volume: 815.8 K
4:15PM ET 8/23/2019
 
 

Incyte Corp ( NASDAQ )

Price: $81.91
Change: -3.65 (4.27%)
Volume: 1.2 M
4:00PM ET 8/23/2019
 
 

Exact Sciences Corp ( NASDAQ )

Price: $116.96
Change: -0.91 (0.77%)
Volume: 1.2 M
4:00PM ET 8/23/2019
 

Read more news Recent News

Sector Update: Top Health Care Stocks Flat to Lower Pre-Market Friday
9:24AM ET 8/23/2019 MT Newswires

Top Health Care Stocks: JNJ: -0.17% PFE: Flat ABT: -0.90% MRK: -0.59% AMGN: -1.2% Top health care stocks were flat to lower in pre-market trading Friday. ...

Sector Update: Health Care
8:54AM ET 8/23/2019 MT Newswires

Top health care stocks were flat to lower pre-market Friday. In other sector news, Alexion Pharmaceuticals (ALXN) was marginally higher after saying the...

--Analyst Actions: JPMorgan Starts Alexion Pharmaceuticals at Overweight, Lowers PT to $172 From $179
10:59AM ET 7/31/2019 MT Newswires

Price: 115.11, Change: +0.66, Percent Change: +0.58 ...

Q3, 2019, and 2020 Earnings Estimates for Alexion Pharmaceuticals Increased
11:36PM ET 7/29/2019 MT Newswires

Q3, 2019, and 2020`s earnings projections for Alexion Pharmaceuticals Inc (NASDAQ:ALXN, Recent Price: 112.36) have been scaled up. The Q3 earnings estimate...

View all Commentary and Analysis

Alexion Pharmaceuticals (ALXN) Jumps: Stock Rises 7.5%
8:15AM ET 8/23/2019 Zacks

Alexion Pharmaceuticals (ALXN) saw a big move last session, as its shares jumped more than 7% on...

Alexion Pharmaceuticals (ALXN) Jumps: Stock Rises 7.5%
8:15AM ET 8/23/2019 Zacks

Alexion Pharmaceuticals (ALXN) saw a big move last session, as its shares jumped more than 7% on...

Alexion Pharmaceuticals (ALXN) Jumps: Stock Rises 7.5%
8:15AM ET 8/23/2019 Zacks

Alexion Pharmaceuticals (ALXN) saw a big move last session, as its shares jumped more than 7% on...

Alexion Pharmaceuticals (ALXN) Jumps: Stock Rises 7.5%
8:15AM ET 8/23/2019 Zacks

Alexion Pharmaceuticals (ALXN) saw a big move last session, as its shares jumped more than 7% on...

Company Profile

Business DescriptionAlexion Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Its products include ultomiris, soliris, strensiq and kanuma. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto and Leonard Bell in January 1992 and is headquartered in Boston, MA. View company web site for more details
Address121 Seaport Boulevard
Boston, Massachusetts 02210
Phone+1.475.230.2596
Number of Employees2,656
Recent SEC Filing07/24/20198-K
Chief Executive Officer & DirectorLudwig N. Hantson
Chief Financial Officer & Executive Vice PresidentPaul J. Clancy
Executive VP, Head-Research & DevelopmentJohn J. Orloff
Chief Compliance Officer & Executive VPIndrani M. Franchini

Company Highlights

Price Open$123.12
Previous Close$123.49
52 Week Range$92.56 - 141.86
Market Capitalization$25.9 B
Shares Outstanding224.2 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement10/23/2019

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings19.48
Earnings per Share$7.31
Beta vs. S&P 500N/A
Revenue$4.1 B
Net Profit Margin29.84%
Return on Equity13.96%

Analyst Ratings as of 07/24/2019

Buy
13
Overweight
3
Hold
3
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset